1. N. N. Anosov, "The shaking palsy or paralysis agitans (Parkinson's disease)," in: Guide to Neurology, Vol. 7 [in Russian], S. N. Davidenkov, ed., Medgiz, Moscow (1960), pp. 256?280.
2. M. Ya. Voloshin, L. F. Burchinskaya, V. S. Zelenskaya, and G. N. Shevko, "Compensation for motor impairment and regeneration processes in the nigrostriatal system and thalamus following systemic administration of the neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)," in: Plasticity of the Nervous System, Vol. 18 [in Russian], O. S. Andrianov, ed., Moscow (1989), pp. 142?144.
3. M. Ya. Voloshin, E. P. Lukhanina, B. P. Kolomiets, et al., "Effects of lesioning the nigrostriatal dopaminergic system induced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on excitatory and inhibitory processes in neurons of thalamic motor nuclei," Neirofiziologiya,21, No. 5, 620?629 (1989).
4. E. I. Kandel, Functional and Stereotaxic Neurosurgery [Russian translation], Meditsina, Moscow (1981).
5. G. N. Kryzhanovskii, M. A. Atadzhanov, V. A. Zagorevskii, et al., "Experimentally-induced Parkinson's syndrome produced by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine," Byull. Éksp. Biol. Med.,105, No. 4, 397?401 (1988).